184ODistant disease-free survival (DDFS) according to response category in neoadjuvant endocrine therapy (NET): 6-year analysis in phase III NEOS trial. (23rd October 2018) - Iwata, H; Masuda, N; Yamamoto, Y; Fujisawa, T; Toyama, T; Taira, N; Kashiwaba, M; Ohtani, S; Sakai, T; Hasegawa, Y; Nakamura, R; Akabane, H; et al.